Q1 2021 Holdings
Filed 2021-05-17 | 46 holdings | $45.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $21.0M | 1,017,524 | 45.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.0M | 317,730 | 17.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $7.2M | 108,000 | 15.6% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $5.8M | 407,055 | 12.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $3.3M | 90,000 | 7.2% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $360.0K | 78,000 | 0.8% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $26.2K | 12,295,767 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $15.2K | 536,820 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $9.9K | 1,095,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.8K | 1,579,093 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $9.3K | 393,548 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.9K | 843,122 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.9K | 118,500 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $8.7K | 767,500 | 0.0% |
| Seelos Therapeutics Inc | COM | 81577F109 | $8.6K | 1,719,812 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $8.3K | 287,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $7.6K | 394,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.4K | 412,500 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $7.4K | 400,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $7.3K | 622,500 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $7.1K | 661,565 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $6.8K | 707,830 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.8K | 357,689 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.7K | 255,180 | 0.0% |
| Verastem Inc | COM | 92337C104 | $5.7K | 2,293,388 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.5K | 562,500 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $5.1K | 154,229 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.9K | 113,161 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $4.7K | 939,500 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $4.4K | 200,289 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.4K | 392,500 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $4.0K | 1,614,000 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.9K | 381,145 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $3.7K | 823,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.1K | 97,574 | 0.0% |
| Vincerx Pharma Inc | *W EXP 12/24/202 | 92731L114 | $2.1K | 520,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.8K | 82,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.7K | 45,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.5K | 9,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.4K | 42,500 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.4K | 315,341 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.4K | 14,000 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $868 | 20,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $569 | 3,136 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $456 | 13,856 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $249 | 93,332 | 0.0% |